tiprankstipranks
Peptidream Inc. (MX:4587N)
:4587N
Mexico Market
4587N
Peptidream
RESEARCH TOOLSreports

Peptidream (4587N) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

4587N Analyst Ratings

Moderate Buy
2Ratings
Moderate Buy
1 Buy
1 Hold
0 Sell
Based on 2 analysts giving stock ratings to
Peptidream
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

4587N Stock 12 Month Forecast

Average Price Target

―
Based on 2 Wall Street analysts offering 12 month price targets for Peptidream in the last 3 months. The average price target is $208.08 with a high forecast of $298.77 and a low forecast of $117.38. The average price target represents a ― change from the last price of ―.
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
Highest Price Target$298.77Average Price Target$208.08Lowest Price Target$117.38
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi Analyst forecast on MX:4587N
Hidemaru Yamaguchi
Citi
Citi
$117.38
Hold
―
Reiterated
07/22/26
Analysts Offer Insights on Healthcare Companies: Celldex (NASDAQ: CLDX), Bristol-Myers Squibb (NYSE: BMY) and Peptidream (Other OTC: PPTDF)
Goldman Sachs Analyst forecast on MX:4587N
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
$298.77
Buy
―
Reiterated
07/17/26
Goldman Sachs Sticks to Its Buy Rating for Peptidream (PPTDF)
SBI Securities Analyst forecast on MX:4587N
Unknown Analyst
SBI Securities
Not Ranked
SBI Securities
$384.14→$341.46
Buy
―
Reiterated
03/02/26
SBI Securities Reaffirms Their Buy Rating on Peptidream (PPTDF)
Nomura Analyst forecast on MX:4587N
Unknown Analyst
Nomura
Not Ranked
Nomura
$288.1
Buy
―
Reiterated
02/17/26
Nomura Sticks to Their Buy Rating for Peptidream (PPTDF)
SMBC Nikko Analyst forecast on MX:4587N
Unknown Analyst
SMBC Nikko
Not Ranked
SMBC Nikko
$288.1
Buy
―
Reiterated
12/10/25
Mizuho Securities Analyst forecast on MX:4587N
Unknown Analyst
Mizuho Securities
Not Ranked
Mizuho Securities
$469.5
Buy
―
Reiterated
12/09/25
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi Analyst forecast on MX:4587N
Hidemaru Yamaguchi
Citi
Citi
$117.38
Hold
―
Reiterated
07/22/26
Analysts Offer Insights on Healthcare Companies: Celldex (NASDAQ: CLDX), Bristol-Myers Squibb (NYSE: BMY) and Peptidream (Other OTC: PPTDF)
Goldman Sachs Analyst forecast on MX:4587N
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
$298.77
Buy
―
Reiterated
07/17/26
Goldman Sachs Sticks to Its Buy Rating for Peptidream (PPTDF)
SBI Securities Analyst forecast on MX:4587N
Unknown Analyst
SBI Securities
Not Ranked
SBI Securities
$384.14→$341.46
Buy
―
Reiterated
03/02/26
SBI Securities Reaffirms Their Buy Rating on Peptidream (PPTDF)
Nomura Analyst forecast on MX:4587N
Unknown Analyst
Nomura
Not Ranked
Nomura
$288.1
Buy
―
Reiterated
02/17/26
Nomura Sticks to Their Buy Rating for Peptidream (PPTDF)
SMBC Nikko Analyst forecast on MX:4587N
Unknown Analyst
SMBC Nikko
Not Ranked
SMBC Nikko
$288.1
Buy
―
Reiterated
12/10/25
Mizuho Securities Analyst forecast on MX:4587N
Unknown Analyst
Mizuho Securities
Not Ranked
Mizuho Securities
$469.5
Buy
―
Reiterated
12/09/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BBOTBridgeBio Oncology Therapeutics
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Peptidream

3 Months
Anthropic BiotechnologyTipRanks - Anthropic
Success Rate
1/1 ratings generated profit
100%
Average Return
+2.80%
reiterated a sell rating 24 days ago
Copying Anthropic Biotechnology's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +2.80% per trade.
1 Year
Anthropic BiotechnologyTipRanks - Anthropic
Success Rate
1/1 ratings generated profit
100%
Average Return
+2.80%
reiterated a sell rating 24 days ago
Copying Anthropic Biotechnology's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +2.80% per trade.
2 Years
Anthropic BiotechnologyTipRanks - Anthropic
Success Rate
1/1 ratings generated profit
100%
Average Return
+2.80%
reiterated a sell rating 24 days ago
Copying Anthropic Biotechnology's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +2.80% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

4587N Analyst Recommendation Trends

Rating
Feb 26
Mar 26
May 26
Jun 26
Jul 26
Strong Buy
7
7
3
1
1
Buy
0
0
0
0
0
Hold
12
19
18
22
31
Sell
0
0
1
3
6
Strong Sell
0
0
0
0
0
total
19
26
22
26
38
In the current month, 4587N has received 1 Buy Ratings, 31 Hold Ratings, and 6 Sell Ratings. 4587N average Analyst price target in the past 3 months is 208.08.
Each month's total comprises the sum of three months' worth of ratings.

4587N Financial Forecast

4587N Earnings Forecast

Next quarter’s earnings estimate for 4587N is -$0.34 with a range of -$0.34 to -$0.34. The previous quarter’s EPS was -$0.71. 4587N beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 52.94% of the time in the same period. In the last calendar year 4587N has Performed in-line its overall industry.
Next quarter’s earnings estimate for 4587N is -$0.34 with a range of -$0.34 to -$0.34. The previous quarter’s EPS was -$0.71. 4587N beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 52.94% of the time in the same period. In the last calendar year 4587N has Performed in-line its overall industry.

4587N Sales Forecast

Next quarter’s sales forecast for 4587N is $605.45M with a range of $605.45M to $605.45M. The previous quarter’s sales results were $508.36M. 4587N beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 71.43% of the time in the same period. In the last calendar year 4587N has Performed in-line its overall industry.
Next quarter’s sales forecast for 4587N is $605.45M with a range of $605.45M to $605.45M. The previous quarter’s sales results were $508.36M. 4587N beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 71.43% of the time in the same period. In the last calendar year 4587N has Performed in-line its overall industry.

4587N Stock Forecast FAQ

What is MX:4587N’s average 12-month price target, according to analysts?
Based on analyst ratings, Peptidream Inc.’s 12-month average price target is 208.08.
    What is MX:4587N’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for MX:4587N, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Peptidream Inc. a Buy, Sell or Hold?
        Peptidream Inc. has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 1 hold ratings and 0 sell ratings.
          What is Peptidream Inc.’s share price target?
          The average share price target for Peptidream Inc. is 208.08. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $298.77 ,and the lowest forecast is $117.38. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Peptidream Inc.?
            Peptidream Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
              How can I buy shares of Peptidream Inc.?
              To buy shares of MX:4587N, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.